Implementation of immunotherapy in recurrent endometrial cancer: a real-world cohort study - 22/10/24

Plan
| The authors have no conflicts of interest to report. A.J.S. received institutional grant funding from GSK and an honorarium from Total Health Conferencing. E.M.K. received institutional grant funding from Bristol Myers Squibb and Tesaro that was unrelated to this work. |
|
| A.J.S. and J.H.’s work was funded by the Basser Center for BRCA. |
Vol 231 - N° 5
P. e174-e185 - novembre 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
